(2S)-2-[4-[2-[(4-carbamimidoylbenzoyl)amino]acetyl]-3-(carboxymethyl)-2-oxopiperazin-1-yl]propanoic acid

C19H23N5O7 — CID 70045546

IUPAC(2S)-2-[4-[2-[(4-carbamimidoylbenzoyl)amino]acetyl]-3-(carboxymethyl)-2-oxopiperazin-1-yl]propanoic acid
SMILES[H]/N=C(\N)c1ccc(C(=O)NCC(=O)N2CCN([C@@H](C)C(=O)O)C(=O)C2CC(=O)O)cc1
InChIInChI=1S/C19H23N5O7/c1-10(19(30)31)23-6-7-24(13(18(23)29)8-15(26)27)14(25)9-22-17(28)12-4-2-11(3-5-12)16(20)21/h2-5,10,13H,6-9H2,1H3,(H3,20,21)(H,22,28)(H,26,27)(H,30,31)/t10-,13?/m0/s1
InChIKeyLTEFDGBGIULWQG-NKUHCKNESA-N
MW433.42 g/mol
LogP-1.31
Rot. Bonds8

About (2S)-2-[4-[2-[(4-carbamimidoylbenzoyl)amino]acetyl]-3-(carboxymethyl)-2-oxopiperazin-1-yl]propanoic acid

(2S)-2-[4-[2-[(4-carbamimidoylbenzoyl)amino]acetyl]-3-(carboxymethyl)-2-oxopiperazin-1-yl]propanoic acid (PubChem CID 70045546) has the molecular formula C19H23N5O7 and a molecular weight of 433.42 g/mol. Its IUPAC name is (2S)-2-[4-[2-[(4-carbamimidoylbenzoyl)amino]acetyl]-3-(carboxymethyl)-2-oxopiperazin-1-yl]propanoic acid.

Molecular Properties

Compound Name(2S)-2-[4-[2-[(4-carbamimidoylbenzoyl)amino]acetyl]-3-(carboxymethyl)-2-oxopiperazin-1-yl]propanoic acid
PubChem CID70045546
Molecular FormulaC19H23N5O7
Molecular Weight433.42 g/mol
Exact Mass433.16
IUPAC Name(2S)-2-[4-[2-[(4-carbamimidoylbenzoyl)amino]acetyl]-3-(carboxymethyl)-2-oxopiperazin-1-yl]propanoic acid
SMILES[H]/N=C(\N)c1ccc(C(=O)NCC(=O)N2CCN([C@@H](C)C(=O)O)C(=O)C2CC(=O)O)cc1
InChIInChI=1S/C19H23N5O7/c1-10(19(30)31)23-6-7-24(13(18(23)29)8-15(26)27)14(25)9-22-17(28)12-4-2-11(3-5-12)16(20)21/h2-5,10,13H,6-9H2,1H3,(H3,20,21)(H,22,28)(H,26,27)(H,30,31)/t10-,13?/m0/s1
InChIKeyLTEFDGBGIULWQG-NKUHCKNESA-N
XLogP-1.31
TPSA194.19 Ų
H-Bond Donors5
H-Bond Acceptors6
Rotatable Bonds8
Heavy Atoms31
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500433.42
LogP ≤ 5-1.31
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze (2S)-2-[4-[2-[(4-carbamimidoylbenzoyl)amino]acetyl]-3-(carboxymethyl)-2-oxopiperazin-1-yl]propanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-2-[4-[2-[(4-carbamimidoylbenzoyl)amino]acetyl]-3-(carboxymethyl)-2-oxopiperazin-1-yl]propanoic acid?
The IUPAC name of (2S)-2-[4-[2-[(4-carbamimidoylbenzoyl)amino]acetyl]-3-(carboxymethyl)-2-oxopiperazin-1-yl]propanoic acid (CID 70045546) is (2S)-2-[4-[2-[(4-carbamimidoylbenzoyl)amino]acetyl]-3-(carboxymethyl)-2-oxopiperazin-1-yl]propanoic acid.
What is the SMILES notation for (2S)-2-[4-[2-[(4-carbamimidoylbenzoyl)amino]acetyl]-3-(carboxymethyl)-2-oxopiperazin-1-yl]propanoic acid?
The canonical SMILES for (2S)-2-[4-[2-[(4-carbamimidoylbenzoyl)amino]acetyl]-3-(carboxymethyl)-2-oxopiperazin-1-yl]propanoic acid is [H]/N=C(\N)c1ccc(C(=O)NCC(=O)N2CCN([C@@H](C)C(=O)O)C(=O)C2CC(=O)O)cc1.
What is the InChIKey of (2S)-2-[4-[2-[(4-carbamimidoylbenzoyl)amino]acetyl]-3-(carboxymethyl)-2-oxopiperazin-1-yl]propanoic acid?
The InChIKey is LTEFDGBGIULWQG-NKUHCKNESA-N. The full InChI is InChI=1S/C19H23N5O7/c1-10(19(30)31)23-6-7-24(13(18(23)29)8-15(26)27)14(25)9-22-17(28)12-4-2-11(3-5-12)16(20)21/h2-5,10,13H,6-9H2,1H3,(H3,20,21)(H,22,28)(H,26,27)(H,30,31)/t10-,13?/m0/s1.
What are the key properties of (2S)-2-[4-[2-[(4-carbamimidoylbenzoyl)amino]acetyl]-3-(carboxymethyl)-2-oxopiperazin-1-yl]propanoic acid?
(2S)-2-[4-[2-[(4-carbamimidoylbenzoyl)amino]acetyl]-3-(carboxymethyl)-2-oxopiperazin-1-yl]propanoic acid has a molecular weight of 433.42 g/mol, XLogP of -1.31, 8 rotatable bonds, 5 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-2-[4-[2-[(4-carbamimidoylbenzoyl)amino]acetyl]-3-(carboxymethyl)-2-oxopiperazin-1-yl]propanoic acid is sourced from PubChem (CID 70045546), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).